Opportunity Overview
Das Open house Verfahren Arzneimittelrabattverträge Erythropoietin zeta, ATC B03AX01, wird mit sofortiger Wirkung zum 30.09.2026 aufgehoben. Alle bestehenden Verträge werden zum 30.09.2026 gekündigt. Der Abschluss von Verträgen ist im Rahmen dieses Open House Verfahrens nicht mehr möglich.
Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | AOK Bayern - Die Gesundheitskasse |
|---|---|
| Country | Germany |
| Category | Health Services |
| Published | August 13, 2026 |
| Procurement stage | Active solicitation |
| Closed | Closing date not published |
| Status | Closed — no longer accepting responses |
| Original language | German — members read it in their own language |
| Official source | View original notice |
| Last verified | October 12, 2026 |
Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.
Browse Similar Open Opportunities in Germany
See every Germany Health Services opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free Germany Health Services intelligence report in your inbox
A personalized report on Germany Health Services opportunities, emailed in 5-10 minutes. One per month, no account needed.